Eighth Symposium on Biologic Scaffolds for Regenerative Medicine

Abstract

The Eighth Symposium on Biologic Scaffolds for Regenerative Medicine was held from 24 to 26 April 2014 at the Silverado Resort in Napa, CA, USA. The symposium was well attended by a diverse audience of academic scientists, industry members and physicians from around the world. The conference showcased the strong foundation of both basic and translational research utilizing biologic scaffolds in regenerative medicine applications across nearly all tissue systems and facilitated vibrant discussions among participants. This article provides an overview of the conference by providing a brief synopsis of selected presentations, each focused on a unique research and/or clinical investigation currently underway.

Acknowledgements

The author would like to thank Dr Badylak and his team members, J Runyon and E Simpson, for their tremendous efforts in organizing and putting on such a first rate event. Additional thanks go to all of the symposium participants for 2 days of insightful presentations and vibrant discussion. Particular thanks go to Drs Vacanti, Niklason, White, Wight, Brown, Mantovani, Slivka, Nieponice and Moalli whose work was discussed herein.

Disclaimer

The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the US Government. The views expressed in this work are those of the author and do not necessarilry reflect the official policy or position of the Department of Army, Department of Defense, nor the US Government.

Financial & competing interests disclosure

Funding for this conference was made possible (in part) by 1 R13 EB 018671–01 from the National Institute of Biomedical Imaging and Bioengineering. Additional funding for this conference was made possible by a number of corporate sponsors, providing unrestricted educational grants, including: C.R. Bard, Inc.; ACell Inc.; Cook Biotech Inc.; Integra Life Sciences Corporation; Harvard Apparatus; RTI Surgical Inc.; Tissue Source, LLC; LifeCell Corporation; Vertex Pharmaceuticals Incorporated; Miromatrix Medical Inc.; International Institute for the Advancement of Medicine. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistant was utilized in the production of this manuscript.

Additional information

Funding

Funding for this conference was made possible (in part) by 1 R13 EB 018671–01 from the National Institute of Biomedical Imaging and Bioengineering. Additional funding for this conference was made possible by a number of corporate sponsors, providing unrestricted educational grants, including: C.R. Bard, Inc.; ACell Inc.; Cook Biotech Inc.; Integra Life Sciences Corporation; Harvard Apparatus; RTI Surgical Inc.; Tissue Source, LLC; LifeCell Corporation; Vertex Pharmaceuticals Incorporated; Miromatrix Medical Inc.; International Institute for the Advancement of Medicine. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistant was utilized in the production of this manuscript.